Clinical Trial Update: Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy [Phase 1]

View source ↗

Summary

Phase 1 results from a study evaluating SBRT for locally recurrent prostate cancer after prior radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostate Cancer, Prostatic Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2023-11-14